ReviewInternational journal of laboratory hematology2022
Plasmablastic lymphoma: An update.
Review in International journal of laboratory hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 56 citations in OpenAlex.
- A Giant Intra-Abdominal Plasmablastic Neoplasm Favoring Lymphoma Mimicking an Exacerbation of Severe Fistulizing Crohn's Disease: A Case Report.The American journal of case reports · 2026Article
- Extracavitary Primary Effusion Lymphoma: Diagnostic Challenges and Differential Diagnosis in a Resource-Constrained South African Setting.International journal of surgical pathology · 2026Article
- Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements.Journal of hematopathology · 2026Article
- Article
- Plasmablastic Transformation of CLL/SLL: The Role of Early NGS Diagnosis and Targeted Multimodal Therapy.Diagnostics (Basel, Switzerland) · 2026Article
- Case Report: Clonal evolution of diffuse large B-cell lymphoma to plasmablastic lymphoma: diagnostic challenges in a case of gastric lesion with EBV-negative PBL.Frontiers in oncology · 2026Article
- Solitary plasmacytoma of maxilla with Epstein Barr virus: A case report and literature review.Journal of clinical and experimental hematopathology : JCEH · 2025Review
- A Rare Case of Plasmablastic Lymphoma With Difficult Diagnosis and Treatment in a Cardiac Transplant Patient.Cureus · 2025Article
- [Clinical characteristics and prognosis of 18 patients with plasmablastic lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2025Article
- Effusion cytology of EBV-associated lymphoma: a concise review.Blood research · 2025Review
- Analysis of clinical characteristics, treatment response, and prognosis among 67 patients with anaplastic multiple myeloma.World journal of surgical oncology · 2025Article
- Plasmablastic lymphoma mimicking primary ovarian, tubal or peritoneal cancer: a case report and literature review.Discover oncology · 2025Article
- Coexistence of plasmablastic lymphoma and adenocarcinoma in the stomach: a case report and literature review.International cancer conference journal · 2025Article
- Unexpected Discovery at Resection Site: Plasmablastic Lymphoma After Polypectomy.ACG case reports journal · 2025Article
- Article
- Case Report: CD19 and CD22 CAR-T therapy induced durable complete remission in a patient with refractory plasmablastic lymphoma.Frontiers in immunology · 2025Article
- Spontaneous Regression of Plasmablastic Lymphoma Associated With Methotrexate After Withdrawal.Journal of hematology · 2024Article
- Cardiac Tamponade Due to Diffuse Large B-cell Lymphoma/Plasmablastic Lymphoma in an Immunocompetent Patient.Cureus · 2024Article
- Sinonasal Plasmablastic Lymphoma: A Systematic Review.Journal of neurological surgery reports · 2024Article
- Epstein-Barr Virus-Negative Plasmablastic Lymphoma Post-liver Transplantation.ACG case reports journal · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasmablastic lymphoma (PBL) is a highly aggressive B cell non-Hodgkin lymphoma frequently associated with immunosuppression, particularly human immunodeficiency virus (HIV) infection. Although PBL is rare globally, South Africa has a high burden of HIV infection leading to a higher incidence of PBL in the region. Laboratory features in PBL may overlap with plasmablastic myeloma and other large B cell lymphomas with plasmablastic or immunoblastic morphology leading to diagnostic dilemmas. There are, however, pertinent distinguishing laboratory features in PBL such as a plasma cell immunophenotype with MYC overexpression, expression of Epstein-Barr virus-encoded small RNAs and lack of anaplastic lymphoma kinase (ALK) expression. This review aims to provide a summary of current knowledge in PBL, focusing on the epidemiology, pathophysiology, laboratory diagnosis and clinical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.